Impact of neoadjuvant multimodal therapy in the setting of locally advanced hepatocellular carcinoma

Abstract

Immunotherapy and the implementation of more aggressive treatment schemes for locally advanced hepatocellular carcinomas have expanded the boundaries of curative options. Because of these advancements, patients who were once considered beyond the aim of a cure are now eligible for liver transplantation and resection.